Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38 USD | 0.00% | +1.01% | -24.89% |
May. 16 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
May. 16 | Sector Update: Health Care Stocks Ease Thursday Afternoon | MT |
Business Summary
Number of employees: 927
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Human Therapeutic Medicines
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 587 | 100.0 % | 788 | 100.0 % | +34.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 12-06-30 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 00-04-30 |
Eugene Schneider
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjay Bhanot
CTO | Chief Tech/Sci/R&D Officer | - | 99-12-31 |
Joel Ekstorm
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tracy Berns
CMP | Compliance Officer | - | - |
C. Bennett
CTO | Chief Tech/Sci/R&D Officer | 67 | 88-12-31 |
B. Parshall
BRD | Director/Board Member | 70 | 91-10-31 |
Dave Ecker
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 14-02-02 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Joan Herman
BRD | Director/Board Member | 70 | 19-06-09 |
Joseph Klein
BRD | Director/Board Member | 62 | 05-12-12 |
B. Parshall
BRD | Director/Board Member | 70 | 91-10-31 |
Joseph Wender
BRD | Director/Board Member | 79 | 93-12-31 |
Director/Board Member | 71 | 02-04-30 | |
Michael Hayden
BRD | Director/Board Member | 72 | 18-09-23 |
Allene Diaz
BRD | Director/Board Member | 59 | 21-06-02 |
Michael Yang
BRD | Director/Board Member | 62 | Dec. 13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 145,965,374 | 144,696,328 ( 99.13 %) | 0 | 99.13 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.89% | 5.54B | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- IONS Stock
- Company Ionis Pharmaceuticals, Inc.